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Lipid bilayerFlavonoids are polyphenolic compounds produced by plants and delivered to the human body through food. Al-
though the epidemiological analyses of large human populations did not reveal a simple correlation between ﬂa-
vonoid consumption and health, laboratory investigations and clinical trials clearly demonstrate the effectiveness
of ﬂavonoids in the prevention of cardiovascular, carcinogenic, neurodegenerative and immune diseases, as well
as other diseases. At present, the abilities of ﬂavonoids in the regulation of cell metabolism, gene expression, and
protection against oxidative stress are well-known, although certain biophysical aspects of their functioning are
not yet clear.Mostﬂavonoids are poorly soluble inwater and, similar to lipophilic compounds, have a tendency to
accumulate in biological membranes, particularly in lipid rafts, where they can interact with different receptors
and signal transducers and inﬂuence their functioning through modulation of the lipid-phase behavior. In this
study, we discuss the enhancement in the lipophilicity and antioxidative activity of ﬂavonoids after their com-
plexation with transient metal cations. We hypothesize that ﬂavonoid–metal complexes are involved in the for-
mation of molecular assemblies due to the facilitation of membrane adhesion and fusion, protein–protein and
protein–membrane binding, and other processes responsible for the regulation of cell metabolism and protection
against environmental hazards.
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ights reserved.1. Introduction
Flavonoids are not synthesized in animal cells, and their presence in
tissues strictly depends on the intake of plant products. Although
1236 Y.S. Tarahovsky et al. / Biochimica et Biophysica Acta 1838 (2014) 1235–1246ﬂavonoids were found to exhibit considerable therapeutic potential in
laboratory experiments, long-time epidemiological analyses on large
human populations did not reveal a simple correlation between ﬂavo-
noid consumption and a decrease in carcinogenic or cardiovascular dis-
eases [1]. The inﬂuence of ﬂavonoids on human health remains unclear.
Unlike universally recognized vitamins, the shortage of ﬂavonoids in
food does not lead to the development of a pronounced deﬁciency syn-
drome; therefore, the original attribution of ﬂavonoids to vitamins, such
as vitamin P, was later declined [2].
The attractiveness of ﬂavonoids is based on their positive inﬂuence
on human health and the therapeutic potential of their synthetic deriv-
atives, including potent anti-inﬂammatory, anticarcinogenic, antiviral,
antiparasitic, and bactericidal chemicals and antibiotics that may reveal
higher efﬁciency than conventional medicines. Moreover, ﬂavonoids
and their derivatives may potentiate the action of other drugs by over-
coming multidrug resistance [3–6]. It is noteworthy that ﬂavonoids
and their chemical derivatives are often less toxic and reveal lower
side effects than derivatives produced from other natural compounds.
Nevertheless, similar to any chemical, ﬂavonoids can be harmful at
high doses. Although the side effects of their intake have not beenwide-
ly studied [7], high doses of puriﬁed ﬂavonoids, which are often sug-
gested by drugstores, should be the subject of concern [8].
Due to themedical use ofﬂavonoids, a considerable increase in studies
on their inﬂuence on human health has been recently observed. During
the last two decades, the number of studies in this area revealed an ap-
proximately tenfold increase and now reaches more than 5000 publica-
tions a year (Fig. 1). This is approximately equal to the number of
studies on drug delivery and twofold higher than the number of studies
on gene therapy. Typically, modern studies of medical plants include a
thorough analysis of their ﬂavonoid composition as a potentially impor-
tant therapeutic factor, and the therapeutic potential of plant remedies
is often attributed to the presence of some ﬂavonoids. Numerous studies
have attempted to improve the therapeutic activity and bioavailability of
ﬂavonoids through chemical modiﬁcation and the use of nanomaterials.
Despite extensive recent investigations, the mechanisms of ﬂavonoid ac-
tion are far from clear. At present, this area of scientiﬁc researchwarrants
further investigation, and the general theory of ﬂavonoid therapeutic ac-
tion remains to be elucidated.
2. Flavonoids as plant polyphenolic compounds
Phenolic molecules consist of one or more aromatic rings bearing
one or more hydroxide groups. Flavonoids represent one of the best
studied and diverse classes of natural polyphenols that are abundantly
present in various plant tissues. The 15-carbon frame of ﬂavonoidsFig. 1. Number of studies on ﬂavonoids performed in different years according to PubMed
(NCBI,MD, USA). The keyword “ﬂavonoids”was used to search the databasewith the Ref-
erence Manager software (ICI ResearchSoft, USA).consists of two aromatic rings (A and B) connected by three carbon
atoms. In general, ﬂavonoids are usually described by the formula
C6\C3\C6 [9], and their classiﬁcation is based on differences in the
structure of the three carbon atoms connecting the aromatic rings. The
distinctive features of this C3 chain are associated with the presence or
absence of the double bond, the choice of carbonyl or carboxyl moiety,
and the possibility of forming a penta- or hexagonal ring C (Fig. 2).
In plant tissues, most ﬂavonoids, excluding ﬂavan-3-ols, are repre-
sented by both aglycones and various glycosides in which the glycoside
part is attached to an oxygen atom that is preferably located in position
3, 7, 3′, or 4′. Glycosides usually bear one or several pyranoside or furan-
oside carbohydrate residues [10] andmay be composed not only of glu-
cose and mannose but also of some rare sugars, such as allose,
galacturonic acid, and apiose [11].
It is difﬁcult to determine the main factors responsible for the inﬂu-
ence ofﬂavonoids on animal health because these compoundsmay con-
trol numerous processes in the bodies of animals that consumeplants as
food. First, we have to mention the antioxidative properties of ﬂavo-
noids [12,13], their ability to inﬂuence functions of ATP-dependent pro-
tein transporters, including ABC transporters of drugs [14], and their
ability to control membrane processes by affecting the ﬂuidity and sta-
bility of the phospholipid bilayer of membranes [15–18]. Here, we sug-
gest that the action of ﬂavonoids may be related to an increase in their
lipophilicity after complexationwith iron cations [19,20], aswas recent-
ly found.
3. Interaction of ﬂavonoids with the phospholipid bilayer
The lipophilicity of ﬂavonoids and their ability to interact with bio-
logical membranes are important factors of their pharmacological activ-
ity. Similar to polyphenols, many ﬂavonoids contain a number of
hydroxyl groups that impart some polarity and weak acidic properties
to the molecules. The inverse correlation between the number of hy-
droxyl groups and the lipophilicity ofﬂavonoids has been demonstrated
experimentally [21]. The interaction with the lipid bilayer depends on
the pH, which determines the electrostatic charges of the ﬂavonoid
and lipid molecules. According to a general rule, a lower pH results in
a lower deprotonation of polar groups and thus a deeper penetration
of ﬂavonoids into the lipid bilayer [22]. Althoughmost ﬂavonoids reveal
some lipophilicity, their glycosides are considerablymorewater-soluble
[23].
Catechins are the subject of many studies on ﬂavonoid/membrane
interactions. Catechins with gallate groups (ECG and EGCG) are better
adsorbed by the lipid bilayer than gallate-free catechins (EC and EGC).
The revealed afﬁnity of catechins to the lipid bilayer decreases in the
order ECG N EGCG N EC N EGC [24–27], which correlates with their lipo-
philicity based on the octanol:water partition coefﬁcient [24]. After ad-
sorption to the bilayer surface, all catechins penetrate into a region
located under phosphate groups and laterally diffuse into the bilayer
plane. Molecular modeling reveals that each molecule of EGCG may in-
teract with 10.8 lipid molecules, which results in a 0.374-nm2 increase
in the bilayer surface [28]. Catechins are unevenly distributed in the bi-
layer plane and reveal a tendency to produce aggregates, as can be ob-
served both in molecular models [29] and in experiments with
liposomes [25]. The heterogeneity of the bilayer leads to the formation
of defects and increases thepermeability of liposomes [30]. NMR studies
have revealed that ﬂavonoids in the lipid bilayer do not penetrate deep-
ly into the hydrophobic region and are located closer to the phosphate
groups,whereas the galloyl groups of ECG and EGCG are found in the vi-
cinity of the trimethylammonium groups of phosphatidylcholine
[31,32]. Moreover, NMR was used to detect the interaction between
the positively charged quarterly ammonium of phosphatidylcholine
and the π-electrons of galloyl groups (cation–π interaction). According
to Uekusa and colleagues, the cation–π interaction may participate in
the stabilization of catechin molecules in the interphase region of the
phospholipid bilayer [31]. In addition, NMR was used to reveal that
Fig. 2. Classiﬁcation of ﬂavonoids based on the structure of the C2\C4 carbon chain (highlighted in bold). An example of the typical enumeration of carbon atoms is presented in the
center.
1237Y.S. Tarahovsky et al. / Biochimica et Biophysica Acta 1838 (2014) 1235–1246the rotation axis of catechin is 55° tilted toward the bilayer plane [31],
whereas the distance between the lipid phosphate and the catechin car-
bonyl is equal to 5.3 ± 0.1 Å.
The ability of ﬂavonoids to interact with the polar/nonpolar regions
of the lipid bilayer was demonstrated by various experimental ap-
proaches. X-ray scattering and molecular simulations revealed that
the ﬂavonoids quercetin, genistein, and daidzein are mainly located
close to the polar area of the bilayer in the region composed of the phos-
phate and carbonyl groups of fatty acids. The long axes of ﬂavonoids are
preferably parallel, whereas the planes of rings are perpendicular to the
bilayer plane [33,34]. Some ﬂavonoids exhibit two-color ﬂuorescence
behavior and can serve as sensitive ﬂuorescent probes for non-
invasive studies of their interaction with the hydrophobic core and
the polar regions of the phospholipid bilayer [35]. It has been found
that polyphenol molecules, including ﬂavonoids, are incorporated
into a relatively hydrophobic fatty acid chain region, where they
are well shielded from water [36]. The phototautomeric behavior of
3-hydroxyﬂavone makes it possible to reveal that one fraction of
this ﬂavonoid is located in the inner hydrophobic core, whereas the
other one resides near the water-accessible surface [37]. Fluorescent
spectroscopy studies revealed that 15% of the ﬂavonoid daidzein is
located in the hydrophobic region of the membrane and that the rest
is distributed in the aqueous bulk and the aqueous/membrane interface
[38]. Fluorescence and EPR spectroscopy techniques demonstrated that
theﬂavonoid genistein is preferentially intercalated in the phospholipid
headgroup region, to some extent in the polar–apolar interface, and to a
minimal extent in the hydrophobic core of the membrane [39]. Genis-
tein provokes a signiﬁcant increase in the membrane order parameter
(which is reciprocally proportional to the membrane ﬂuidity), whereas
no similar effects were observed for daidzein. Accordingly, it was
suggested that genistein may exert its anti-metastatic effects by chang-
ing themechanical properties of prostate cancer cells, whereas daidzeinshould be applied at higher concentrations than genistein to achieve
pharmacological effects [16]. According to data obtained using the
FTIR, 1H NMR, and EPR techniques, the ﬂavonoid apigenin incorporates
into the bilayer of DPPC liposomes via overcoming the hydrogen bond-
ing between its own hydroxyl groups and the lipid polar head groups in
the COPOC segment. It has been hypothesized that the hydroxyl groups
of apigenin linkwith the polar groups of DPPC bywater bridges. Thisﬂa-
vonoid may exert a strong rigidifying effect on polar head groups [40].
4. Penetration of ﬂavonoids through membranes of the intestinal
epithelium
The daily consumption of ﬂavonoids depends on the diet and varies
from tenths of milligrams to a few grams [1,41]. In the intestinal lumen,
ﬂavonoid-O-glycosides are attacked by hydrolases exhibiting multiple
enzymatic activities, which results in the release of ﬂavonoid aglycones.
The aglycones are delivered to thehumanbody through themembranes
of the intestinal epithelium, which covers more than 90% of the intesti-
nal surface [42]. The bioavailability of ﬂavonoids is very low. Less than
1% of the consumed ﬂavonoids enter the blood [43].
The hydrolysis of ﬂavonoid glycosides by β-glucosidase and the sub-
sequent attachment of glucuronic acid occur after the penetration of the
glycosides into the cytoplasm of enterocytes, which are the cells of the
intestinal epithelium [44]. Furthermore, the portal vein transports
these substances to the liver, where they are methylated and sulfated
with appropriate transferases [45]. Thus, in the blood, only 5–10% of
theﬂavonoids are notmodiﬁed [46], whereas glucuronides are predom-
inant [47].
Among the foodstuffs that are consumed daily, tea contains the larg-
est amount of ﬂavonoids. First, we should mention that green tea con-
tains up to 30% catechins, as calculated based on the weight of dry
leaves [48]. Two hours after the consumption of one cup of green or
Fig. 3. Structure of rafts. (A) Sphingomyelin and cholesterol packing in a raft located on the
external leaﬂet of the plasma membrane. It is hypothesized that the cytoplasmic leaﬂet of
themembrane is alsomodiﬁed in the area apposed to the raft. (B) Organization of proteins
in the raft (the same fragment of the plasma membrane is presented). Transmembrane
proteins (a) and (b) enter the raft and produce a functionally active complex (a–b). Pe-
ripheral proteins attached to cholesterol (c) or glycophospholipids (d) are also present
in the raft. After palmitoylation, some proteins can be recruited in the area apposed to
the raft on the cytoplasmic leaﬂet (f).
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doses, the concentration of catechins can reach 10 μM [49–51]. The bio-
availability of quercetin, naringenin, or hesperidin is lower than that of
catechins, but their concentration in blood can also reach tens or hun-
dreds of nanomoles per liter when large amounts of fruits and vegeta-
bles are consumed [52].
The mechanism through which ﬂavonoids overcome the hydropho-
bic barrier of cell membranes remains to be fully elucidated. It is well
known that ﬂavonoid aglycones are only slightly soluble in water and
sufﬁciently lipophilic for spontaneous penetration through the lipid bi-
layer. Although ﬂavonoids are preferably found in the periphery of the
lipid bilayer, the probability of their presence at the center of the bilayer
is not zero, as calculated from the free energy proﬁle, which allows a ﬂa-
vonoid molecule to spontaneously cross the bilayer [33].
Water-soluble glucosides of ﬂavonoids, such as quercetin mono-
glucosides, but not diglucosides can pass over epithelium membranes
via the glucose transporters GLUT-1 [53,54] and GLUT2 [55]. The
transporter-dependent translocation of quercetin glucosides was
found to bemore efﬁcient than the spontaneous penetration of querce-
tin aglycones through the lipid bilayer [44]. Moreover, themain insulin-
regulated glucose transporterGLUT4may also participate in the translo-
cation of hydrophobic ﬂavonoid aglycones [56]. It is interesting that the
ﬂavonoid genistein can inhibit this transporter, thereby regulating the
insulin-dependent glucose transport in adipocytes [57]. Similarly, the
ﬂavonoids naringenin [58] and phlorizin [59] can decrease the adsorp-
tion of sugars by the intestinal epithelium, which could be useful in di-
abetes treatment. The bilirubin transporter bilitranslocase is also
involved in the transport ofﬂavonoids in gastrointestinal [60] and endo-
thelial cells [61]. In contrast, ﬂavonoids can inhibit themonocarboxylate
transporters MST2 and SLC-16, which are responsible for the transloca-
tion of lactates, pyruvates, ketone bodies [62], and various drugs [63];
however, to the best of our knowledge, the involvement of these trans-
porters in ﬂavonoid translocation has not been studied.
5. Lipid rafts and caveolae
Cell membranes represent a complex mosaic structure. The nonran-
domdistribution of lipids as a result of molecular segregation and the for-
mation of domains can be observed even on artiﬁcial bilayers composed
of lipids with different melting temperatures [64]. The formation of mo-
lecular domainsmay lead to variations in the compositions of neighboring
areas of the bilayer [64,65]. One of the most studied mosaic structures,
which are known as lipid rafts, was initially found in apical membranes
of epithelial cells enriched with sphingomyelin and cholesterol [66], and
numerous studies on lipid rafts were then performed on different cells.
It was detected that lipid rafts are located on the external leaﬂet of the
plasma membrane and consist of tightly packed domains of cholesterol
and saturated sphingomyelin that ﬂoat in a lake of melted and loosely
packed unsaturated lipids. The ﬁnal deﬁnition of rafts as “small
(10–200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-
enriched domains that compartmentalize cellular processes” was pre-
sented on a Keystone Symposium in 2006 [67].
It was found that rafts participate in various biological processes, in-
cluding the viral [68,69], bacterial [70], parasitic [71], and fungal infec-
tion of cells [72]. Moreover, rafts are involved in apoptosis, immune
response, cell signaling, and communication processes [73]. Distur-
bances in cell signaling processes in lipid rafts result in various
membrane-related dysfunctions [74], including inﬂammation [75], im-
mune disorders [76,77], pathology of liver [78] and of cardiovascular
systems [79], atherosclerosis [80], and neuronal degeneration [81].
Rafts are rich in various proteins. For example, the
glycophosphatidylinositol-anchored protein (GPI-AP) is able to diffuse
laterally in rafts and produce dimers with cholesterol [82]. Moreover,
proteins covalently attached to palmitic acid [83] or covalently attached
to cholesterol [84] also have a tendency to accumulate in rafts (Fig. 3).
The proteins present in rafts, such as receptors [85] and channelproteins [86], may participate in cell regulatory processes. For example,
the Hedgehog protein (Hh) attached to the membrane through
palmitoylation or cholesterinization [87] accumulates in rafts and par-
ticipates in cell signaling during embryogenesis [88,89]. It was found
that a similar raft protein, namely Sonic Hedgehog (SHh), can be used
as a target for the therapeutic treatment of damaged brain tissues
[90], different cancers [91–95], and cardiovascular disorders [96]. The
tumor necrosis factor receptor (TNFR), which is responsible for apopto-
sis, is also accumulated in rafts and can be used for the treatment of can-
cer cells [97].
Some rafts are involved in the processes of caveolar endocytosis. Ca-
veolae are regarded as a special group of rafts present in the plasma
membrane of different cells, including endothelium, smoothmuscles,ﬁ-
broblasts, and adipocytes [98–100]. Similar to other rafts, caveolae are
rich in cholesterol and sphingomyelin and also contain caveolin pro-
teins responsible for plasmamembrane invaginations during endocyto-
sis (Fig. 4) [101].6. Delivery of ﬂavonoids to lipid rafts
When present in blood, ﬂavonoids interact with different water-
soluble proteins, particularly albumins. This interaction was described
in studies of kaempferol, galangin, diosmetin [102], luteolin, taxifolin,
catechins [103], and otherﬂavonoids. The interaction of dihydrochalcone
with bovine serum albumin (BSA) was found to be spontaneous, con-
trolled by hydrophobic forces, and accompaniedwith a release of energy
[104]. The spontaneous interaction with site II of subdomain IIIA of BSA
was described for morin [105], whereas apigenin interacts with site I of
subdomain II of BSA [106]. A similar site of human serum albumin
Fig. 4. Schematic representation of a caveolae structure. (A) On the plasmamembrane, ca-
veolae appear as numerous invaginations with a diameter of 60–80 nm that can enter the
cytoplasmduring endocytosis. (B) Caveolinmolecules are attached to the cytoplasmic sur-
face of caveolae. (C) The external leaﬂet of the caveolar membrane contains cholesterol
and sphingomyelin, similar to other rafts. Caveolin has a hydrophobic domain that enters
the cytoplasmic leaﬂet of the bilayer. Moreover, this protein is covalently attached to the
bilayer through cholesterol and palmitin. The former is located on the positively charged
caveolin site known as the scaffolding domain.
1239Y.S. Tarahovsky et al. / Biochimica et Biophysica Acta 1838 (2014) 1235–1246(HSA) was occupied by ﬁsetin [107]. The binding constant of hesperetin
to HSAwas 1.941× 104М−1 [108], and the binding constant of the inter-
action of EC with site II of subdomain IIIA of BSA was 106М−1, whereas
the binding constant of EGCG with site I of subdomain IIA of BSA was
6.6 × 107 М−1. It was hypothesized that the reported difference in
the binding of catechins can be attributed to the inﬂuence of galloid
groups [109].
Flavonoids can also interact with lipoproteins present in blood. Thus,
quercetin interacts with low-density lipoproteins (LDL). A protective ef-
fect of quercetin against the toxic and apoptotic inﬂuences of oxidized
LDL was demonstrated on macrophages [110]. A similar protective effect
against oxidative stress was observed with delphinidin-3-glucoside
adsorbed on LDL [111].
The albumins and lipoproteins of blood are delivered to rafts present
on the plasma membrane of different cells and enter the cytoplasm
through caveolin-dependent endocytosis. There is considerable evidence
for the involvement of caveolae in the endocytosis and transcytosis of
LDL and albumins [110,112,113]. We hypothesize that ﬂavonoids can
be delivered to rafts with LDL and albumins and that the presence of
these compounds in fact may inﬂuence the functioning of some reg-
ulatory systems. A number of remarkable suggestions regarding the
regulatory properties of ﬂavonoids in rafts were recently presented.7. Inﬂuence of ﬂavonoids on rafts and caveolae
The ability of ﬂavonoids to interact withmembrane rafts and caveo-
lae has been studied in many laboratories. It has been found that green
tea EGCG can inﬂuence cell signaling and attenuate inﬂammatory pro-
cesses in endothelium cells by decreasing the expression of caveolin-1
and cyclooxygenase COX-2 and inhibiting the ERK 1/2 and Akt kinases
of the MAPK signaling pathway [114]. A similar ability to decreasecaveolin-1 expression and activate signaling through PI3K and Akt ki-
nases,which are responsible for the regulation of apoptosis and carcino-
genesis, was also found in studies of the ﬂavonoid daidzein [115].
In cerebral ischemia, the elevated permeability of the blood brain
barrier (BBB) is a characteristic feature of the injured area. It has been
demonstrated that green tea polyphenolsmay decrease the BBB perme-
ability and thus lead to considerable amelioration of the damaged tis-
sues. The observed changes in the permeability correlate with the
downregulation of the expression of caveolin-1 in endothelial cells re-
sponsible for BBB integrity. In addition, an increase in the expression
and phosphorylation of raft ERK1/2 kinases responsible for cell prolifer-
ation has also been observed [116].
In endothelial cells, the downregulation of caveolin-1 expression by
green tea polyphenols may protect the aorta against the pathological
changes induced by a high-fat diet. It is well known that caveolin-1 is
a negative regulator of nitric oxide synthase (eNOS). A high-fat diet
upregulates the aortic caveolin-1 expression, whereas green tea poly-
phenols normalize the level of this protein and subsequently the nitric
oxide concentration responsible for autoimmune and inﬂammatory
processes. The observed regulation of caveolin-1 expression is con-
trolled by the protein kinases ERK1/2 and p38 MAPK, which are also
present in rafts [117].
The glycoprotein laminin belongs to a family of scaffolding proteins
that are present in most tissues. Cancer cells reveal elevated amounts
of laminin receptors in plasma membrane rafts, which results in tumor
metastasis. Green tea EGCG may prevent carcinogenesis by blocking
the interaction of epithelium growth factor (EGF) with the correspond-
ing receptor (EGFR) present in rafts [118]. As was demonstrated in a
study of multiple myeloma, EGCG can initiate the apoptosis of cancer
cells without adversely affecting normal cells. The apoptotic activity of
EGCG is explained by its ability to initiate the accumulation of the lami-
nin receptor in lipid rafts of multiple myeloma cells but not in normal
blood mononuclear cells. Moreover, EGCG induces the phosphorylation
of protein kinase C (PKC) and the translocation of acid sphingomyelinase
to the plasma membrane, which results in the apoptosis of myeloma
cells [119]. A similar clustering of raft proteins in the presence of EGCG
or green tea extract was found in human colon adenocarcinoma COLO
204 cells, but surprisingly, this process leads to the upregulation of can-
cer cell viability through the MEK/ERK1/2 signaling pathway [120].
The protective antiatherosclerotic effect of green tea catechins is ex-
plained by their anti-inﬂammatory inﬂuence on vascular endothelial
cells. The induction and compartmentalization of the heme oxygenase-
1 enzyme in lipid rafts and caveolae play an important protective role
against atherosclerosis. It has been found that EGCG initiates caveolin
displacement from the inner surface of the membrane toward the cyto-
plasm. Moreover, treatment with EGCG activates the production of the
nuclear factor of transcription Nrf2, which is responsible for protection
against oxidative stress and inﬂammation of the endothelium [121].
The hepatocyte growth factor HGF and the receptor for this protein,
which is known as c-Met, are involved in the regulatory pathway re-
sponsible for the invasion and metastasis of most human cancer cells.
In tumor cells, c-Met accumulates in lipid rafts only after its phosphor-
ylation. It has been demonstrated that EGCG can downregulate carcino-
genesis by preventing the phosphorylation of the c-Met receptor. This
activity was demonstrated only for catechins containing galloid moie-
ties [122]. It was previously reported that luteolin can also block the
phosphorylation of the c-Met receptor of tyrosine kinase, even though
this ﬂavonoid contains no galloid groups [123].
The well-known hypocholesterolemic effect of green tea can be due
to the presence of gallocatechins [124,125]. It is known that cholesterol
is normally removed from blood, delivered to the duodenum, and ex-
creted from the body after its oxidation into bile salts catalyzed by cyto-
chrome P450. However, considerable amounts of bile salts can be
reabsorbed in the ileum with the apical sodium bile acid transporter
ASBT. It was demonstrated that EGCG inhibits the ASBT transporter
and thus decreases the presence of this protein in lipid rafts, where
1240 Y.S. Tarahovsky et al. / Biochimica et Biophysica Acta 1838 (2014) 1235–1246the transport process takes place, which results in the normalization of
the cholesterol content in the blood [126].
Quercetin can also inﬂuence the regulatory processes in caveolae.
The anti-inﬂammatory activity of quercetin is explained not only by
its antioxidative properties but also by its inhibition of nitric oxide
production and its downregulation of various kinases present in rafts,
including c-Jun, p38, Akt, Src, JAK-1, Tyk2, andNF-κB.Moreover, querce-
tin inhibits serine–threonine and tyrosine phosphatases [127] and en-
sures that toxic polychlorodiphenols (PCD) do not activate the
caveolin-regulated signaling cascades responsible for inﬂammation
and atherosclerosis. As was demonstrated in colon cancer cells, querce-
tin can induce the accumulation of the death receptors DR4 and DR5,
which promote the TRIAL-induced apoptosis of tumor cells, in rafts
[128]. Quercetin inhibits the expression of caveolin, CYP1A1, and the
cell-adhesion molecules (VCAM-1) selectins E and C. Thus the protec-
tive effect of quercetin is explained by its direct inﬂuence on the caveo-
lae [129]. Other ﬂavonoids, such as the phytoestrogen genistein, can
restore the raft levels of caveoline-1 and angiotensin receptor AT-1,
which are decreased after ovariectomy in experimental hypertensive
animals,which results in the normalization of the cardiovascular system
[130].
8. Metal-chelating properties of ﬂavonoids
8.1. Biological and medical relation
The antioxidative properties of ﬂavonoids are based not only on
their free-radical scavenging ability but also on their chelation of tran-
sient metals [131–133]. Moreover, ﬂavonoid complexes with iron,
cupper, and other cations reveal superoxide dismutase activity
[134,135]. The protective properties of ﬂavonoid–metal complexes
have been demonstrated both in vitro and in vivo. For example, rutin
complexes with Fe2+, Fe3+, Cu2+, and Zn2+ to effectively protect the
animal lung against asbestos-induced injury [136]. Complexes of
morin with Pd(II) or Pt(II) are also active toward superoxide radicals
[137].
Somemetal complexes of ﬂavonoids reveal toxicity to cancer or bac-
terial cells. For example, quercetin complexes with trivalent cations of
rare-earth metals (La, Nb, Gd, Tb, Dy, Tm, and Y) were found to be
toxic to tumor cells, likely due to their ability to speciﬁcally interact
with DNA [138–140]. High antioxidant activity and ability to interact
with DNA were also found for rare-earth Y(III) and Eu(III) complexes
with naringenin-2-hydroxy benzoyl hydrazone ligand [141] or com-
plexes of Ln(III) with hesperetin-4-one-(benzoyl) hydrazone. Com-
plexes of morin with La(III), Gd(III), and Lu(III) revealed very high
antibacterial activity, comparable to that of penicillin, against
Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus [142].
The high protective ability of ﬂavonoid–metal complexes revealed in
experiments with cells, tissues, and animals [131–133,143,144] sug-
gests perspectives regarding their medical use [145].
8.2. Physical and chemical properties of ﬂavonoid–metal complexes
It is generally accepted that the two neighboring hydroxyls or neigh-
boring carboxyl and hydroxyl groups of ﬂavonoids are responsible for
the metal chelating ability of these compounds. In ring B, the 3′ and
4′-hydroxyl groups,which are knownas catechol groups, are very active
in the chelation of metals. These catechol groups are present not only in
catechins but also in quercetin, taxifolin, and some other ﬂavonoids. In
ring C, the 3-hydroxyl-4-carbonyl and 5-hydroxyl-4-carbonyl groups
can also participate in metal chelation. The chelation forces are in-
creased in an alkaline environment (pH 10) due to the deprotonation
of hydroxyls. The above-described chelation sites were studied on
many ﬂavonoid–metal complexes, such as the complex of quercetin
with Cu(II) [146]. Not all ﬂavonoids have catechol groups, and the num-
ber of hydroxyls in ﬂavonoid molecules can differ. For example,naringenin glycoside has only one position in the 5-hydroxyl-4-
carbonyl group for metal chelation. In addition, it was found that the in-
teraction of naringenin glycoside with Cu(II) increases its antioxidative
and anti-inﬂammatory activities. Moreover, its complexation with
cupper endows this compound toxic activity against tumor cells [147].
If a ﬂavonoid hasmore than one site formetal chelation, the position
of the metal atom and the stoichiometry of the complex are rather dif-
ﬁcult to establish, and this point requires further investigation. Thus,
complexes of Fe(II) and Fe(III) cations with quercetin may exhibit dif-
ferent stoichiometries and different sites for metal chelation. Molecular
modeling [148] has revealed that the preferred site of chelation is locat-
ed on the 3-hydroxyl-4-carbonyl group, followed by the 4-carbonyl-5-
hydroxyl and the 3′- and 4′-carboxyl groups. Accordingly, iron can pro-
duce complexes with one, two, or three molecules of quercetin (Fig. 5).
The complexation of ﬂavonoids withmetal cations can considerably
change their lipophilicity and interactionwith the lipid bilayer. The dis-
tribution coefﬁcient calculated for different complexes in octanol-water
(CLogP) revealed that a complex of quercetin:iron with a stoichiometry
of 1:1 is less lipophilic than free quercetin, although the lipophilicity ob-
tained with different stoichiometries increased in the following order:
2:1 b 3:2 b 3:1 (see Table 1). The experimental analysis also revealed
an increase in quercetin and taxifolin lipophilicity after chelation with
iron(II), although the experimentally obtained values of LogPwere con-
siderably lower than those calculated using molecular models [19].8.3. Interaction of ﬂavonoid–iron complexes with lipid bilayer and proteins
Iron is an essential element of nutrition, and its deﬁciency causes the
spread of anemia both in developing and in industrial countries. Poly-
phenols are among the factors that are potentially able to restrict the
bioavailability of iron due to the production of low-soluble complexes
[149]. For example, tea catechins prevent normal iron adsorption from
the gut in populations that are already at risk of anemia but are not
harmful to healthy people [150]. The iron-chelating abilities of different
ﬂavonoids are efﬁcient for protection against oxidative stress in sickle
cell anemia [151,152], rheumatoid arthritis [153], thalassemia, and
Fanconi's anemia [154,155], which are disorders characterized by ele-
vated concentrations of free iron cations in the blood.
Although the solubility ofﬂavonoids inwater is low, these compounds
can interact with biological membranes, penetrate into the phospholipid
bilayer, and inﬂuence the phase behavior of lipids. These molecules
change the melting temperature of phosphatidylcholine and the bilayer/
hexagonal HII phase transition of phosphatidylethanolamine [156,157].
Metal cations can increase the lipophilicity of ﬂavonoids and modify
their inﬂuence on lipid-phase transitions. For example, complexes of
quercetin with iron(II) increase the temperature of the bilayer/hexagonal
HII phase transition in phosphatidylethanolamine liposomes to a consid-
erably stronger degree than free quercetin [19].
The observed changes in the temperature of the bilayer/hexagonal
HII phase transition of phosphatidylethanolamine may have an impor-
tant biological effect, although it should be noted that this lipid is not
present in lipid rafts but is preferentially located in the internal leaﬂet
of the plasma membrane apposed to rafts [158]. The observed changes
in the bilayer/hexagonal HII phase transition may inﬂuence cell signal-
ing through G protein-coupled receptors, including the adrenergic
receptor [159] and rhodopsin [160]. The involvement of plant polyphe-
nols in the regulation of G protein-coupled receptors through the lipid
environment may help prevent Alzheimer's disease [161], numerous
age-relative disorders [162], blood pressure disorders [163], and cancer
[164]. The bilayer/hexagonal HII phase transition may also control nu-
merous processes related to membrane fusion [165] and the penetra-
tion of virus particles and peptide toxins via the membrane [166,167].
Moreover, the abovementioned transition can inﬂuence the antibacteri-
al [168–170] and antiparasitic [171] activities of various compounds, in-
cluding drugs.
Fig. 5. Probable structure of some quercetin–Fe complexes with stoichiometries of 1:1 (a–c), 2:1 (d), 3:2 (e), and 3:1 (f) [148,198].
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initiate liposome aggregation and fusion in the presence of iron(II)
and calcium cations [20]. For example, freeze-fracture electron micros-
copy revealed the adhesion and fusion of small liposomes, which result-
ed in an increase in their size and the formation of gigantic liposomes
(Fig. 6). When two or three ﬂavonoid molecules interact with a metal
cation, the lipophilicity of the complex increases because the most
polar sites ofﬂavonoidmolecules are buried inside themolecular aggre-
gate. This polar moiety containing an atom of a transient metal could
produce a bridge exposed to water, whereas the hydrophobic parts of
the ﬂavonoids are attached to the adjacent bilayers. Thus, a ﬂavonoid–
metal complex functions as a molecular fastener that may connect
two adjacent lipid bilayers. Cations of calcium may facilitate adhesion
between membranes, but they interact with negatively charged phos-
phates located on the polar heads of lipids [20].
The ability of polyphenolic compounds, such as tannic acids, to initi-
ate the aggregation and adhesion of membranes has been discovered
[172,173]. It was demonstrated that tannin molecules can produceTable 1
Calculated distribution coefﬁcients in octanol/water system
(lipophilicity) obtained from molecular models of quercetin
and complexes of quercetin with iron cations. Modeling in
ChemBio3D Ultra software (Perkin Elmer, USA).
Compound CLog P
Quercetin 1.30757
Quercetin/iron (1:1) 0.86626
Quercetin/iron (2:1) 3.47752
Quercetin/iron (3:2) 5.5498
Quercetin/iron (3:1) 6.08878bridges between adjacent bilayers. Flavonoid molecules are consider-
ably smaller than tannins, and a single ﬂavonoid molecule cannot pro-
duce an interbilayer bridge, whereas two molecules connected by a
metal atom can be involved in the processes of intermolecularFig. 6. Freeze-fracture electron microscopy of the adhesion and fusion of 100-nm phos-
phatidylcholine liposomes in the presence of quercetin–Fe2+ and Ca2+ [20]. (A) Original
suspension of liposomes. (B) Liposomes after the addition of ﬂavonoid andmetals. The gi-
gantic liposomes (marked by asterisk) appear as a result ofmembrane fusion. Some points
of small liposome adhesion and fusion on the surface of a gigantic liposome are indicated
by arrowheads.
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the hydrophobic sites (pockets) of proteins may also provide a possible
hosting site for ﬂavonoids, whereas metal atoms can be involved in in-
termolecular interactions, whichmay result in the clustering of proteins
in membranes, protein adsorption on the membrane surface, or oligo-
merization of water-soluble proteins.9. Involvement of ﬂavonoids in intermolecular and intercellular
coupling
Numerous studies have revealed the ability of ﬂavonoids to partici-
pate in intermolecular and intercellular interactions, although our
knowledge of the involvement of transient metal cations in the process
is scarce. It was found that ﬂavonoids can inﬂuence the polymerization
of some proteins to produce protein ﬁbers. For example, there is evi-
dence of the ability of taxifolin to initiate the formation of stable colla-
gen ﬁbers from monomers of this protein [174]. Catechin gallates of
green tea can effectively protect Vero cells against damage induced by
E. coli enterotoxin by producing large insoluble aggregates of enterotox-
in [175]. EGCG can induce the aggregation of erythrocytes through cova-
lent catechol–protein adducts with the sulfhydryl groups of membrane
proteins [176]. Some ﬂavonoids, including hesperetin, naringenin, daid-
zein, and morin, increase the integrity of the tight junction barrier re-
sponsible for the functioning of intestinal epithelium Caco-2 cells
through modulation of the protein–membrane association [177].
The antibacterial effect of ﬂavonoids can be explained by the aggre-
gation of bacterial cells and damage to the bacterial membrane. The ag-
gregation of cells can decrease their access to oxygen and facilitate theFig. 7.Amodel of a quercetin–iron “fastener” that (A) holds together adjacent lipid bilayers.
Calcium cations interact with the negatively charged phosphate groups of lipids and con-
tribute to the interbilayer forces of adhesion, (B) initiates the aggregation ofmembrane pro-
teins, (C) participates in the adsorption of proteins to the membrane surface, and
(D) initiates the oligomerization or formation of water-soluble protein ﬁbers. It is hypothe-
sized that ﬂavonoids penetrate into the hydrophobic site of the lipid bilayer or into hydro-
phobic protein pockets.accumulation of waste products to prevent proliferation and induce
the initiation of cell death [178]. The aggregation of bacterial cells after
their treatment with EGCG was accompanied by the anti-bactericidal
activity of this ﬂavonoid, whereas less-bactericidal ﬂavonoids did not
initiate aggregation processes [179]. As a result of protein aggrega-
tion, EGCG can inactivate toxic enzymes extracted from bacterial
membranes [180]. Synthetic 3-arylideneﬂavanones were found to
be highly active against S. aureus, S. epidermidis, and E. faecalis due
to ﬂavonoid-initiated bacterial cell aggregation and bioﬁlm distur-
bance [181].
Despite the evidence presented above, there are numerous observa-
tions that ﬂavonoids prevent the intermolecular interactions of proteins,
the formation of cell membrane contacts, and membrane fusion. For ex-
ample, it has been shown that the oligomerization of some proteinsmay
cause mental disorders, including Parkinson's and Alzheimer's diseases.
The protective effect of the ﬂavonoids baicalein, apigenin, morin, and
black tea extract is explained by their ability to prevent the oligomeriza-
tion of human alphaS protein, which is responsible for Parkinson's dis-
ease [182]. Quercetin, green and black tea extracts, cyanidins, and
extracts of grape seed are effective inhibitors of Abeta protein aggrega-
tion and the assembly of amyloidﬁbers,which are responsible for the de-
velopment of Alzheimer's disease [183–186].
The ﬂavonoids apigenin, quercetin, and cirsimaritin favor erythro-
cyte deformability and prevent their aggregation to ensure the mainte-
nance of their ﬁlterability [187]. Soy isoﬂavones, naringin, quercetin,
and many other ﬂavonoids may inhibit platelet aggregation initiated
by toxic compounds [188–190]. The ﬂavonoid eupatilin, which is
known as an anti-inﬂammatory compound, prevents the adhesion of
monocytes and eosinophils to bronchial epithelial cells [191]. As was
demonstrated on human hepatoma cells, the anticancer properties of
baicalein can be explained by its ability to prevent the adhesion, migra-
tion, and invasion of cancer cells [192]. The inhibition of cell adhesion to
ﬁbronectin may explain the protective ability of EGCG against various
retinopathies [193].
The prevention of membrane fusion is a mechanism through which
ﬂavonoids protect an organism against viral infection. For example, it
has been demonstrated that theaﬂavins have the potential to be devel-
oped as effective topical drugs for the prevention of the HIV-1 viral fu-
sion with the cell membrane mediated by the HIV-1 envelope protein
[194]. EGCG fromgreen tea signiﬁcantly decreases the entry of the inﬂu-
enza A virus into nasal epithelial cells [195]. Theﬂavonolignans silybinA
and silybin B prevent liver infection with the hepatitis C virus by
targeting multiple steps in the viral lifecycle, including by preventing
the fusion of viral particles to membranes [196,197].
10. Conclusions
Flavonoids are polyphenolic compounds produced by plants for
their protection against different environmental hazards. Animals and
human do not produce ﬂavonoids but consume them daily through
food. Thus, throughout evolution, ﬂavonoids are constantly present in
our body. Although sometimes ignored, ﬂavonoids can inﬂuence vari-
ous cellular processes, including membrane transport, protein assem-
bly, cell signal transduction, and gene expression. Flavonoids maintain
our health and protect us against toxins and infections.
Flavonoids are able to penetrate into the hydrophobic and inter-
phase sites of biological membranes, particularly compartments
known as lipid rafts. The inﬂuence of ﬂavonoids on the physical proper-
ties of the lipid bilayer may control the arrangement of membrane pro-
teins and the formation of functional complexes responsible for cell
signal transduction and the regulation of the metabolism.
Flavonoids are known as powerful antioxidants and chelators of
transient metals involved in oxidation. Flavonoid complexes with iron
cations are worthy of special consideration because both components
are present in abundance in the human body. After complexing with
metals, the antioxidative potential and lipophilicity of ﬂavonoids may
1243Y.S. Tarahovsky et al. / Biochimica et Biophysica Acta 1838 (2014) 1235–1246increase, thereby facilitating the protection of membrane lipids against
oxidation. Moreover, ﬂavonoid–metal complexes may function as
molecular “fasteners” that penetrate into the hydrophobic sites of
membranes or proteins and initiate their adhesion and aggregation.
These processes may participate in cell–cell interaction and protein
clusterization andmay provide protection against infection and disease.
To obtain a better understanding of the involvement of ﬂavonoids in the
health control, their complexation with transient metals should be in-
vestigated in more detail.
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